178 related articles for article (PubMed ID: 21972248)
21. Design and QSAR study of analogs of alpha-tocopherol with enhanced antiproliferative activity against human breast adenocarcinoma cells.
Nikolic KM
J Mol Graph Model; 2008 Jan; 26(5):868-73. PubMed ID: 17616411
[TBL] [Abstract][Full Text] [Related]
22. 9-Arylimino noscapinoids as potent tubulin binding anticancer agent: chemical synthesis and cellular evaluation against breast tumour cells.
Patel AK; Meher RK; Nagireddy PK; Pragyandipta P; Pedapati RK; Kantevari S; Naik PK
SAR QSAR Environ Res; 2021 Apr; 32(4):269-291. PubMed ID: 33687299
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
[TBL] [Abstract][Full Text] [Related]
24. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
[TBL] [Abstract][Full Text] [Related]
25. Use of Quantitative Structure-Activity Relationship (QSAR) and ADMET prediction studies as screening methods for design of benzyl urea derivatives for anti-cancer activity.
Lokwani D; Bhandari S; Pujari R; Shastri P; Shelke G; Pawar V
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):319-31. PubMed ID: 20846089
[TBL] [Abstract][Full Text] [Related]
26. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).
Naik PK; Lopus M; Aneja R; Vangapandu SN; Joshi HC
J Comput Aided Mol Des; 2012 Feb; 26(2):233-47. PubMed ID: 22170255
[TBL] [Abstract][Full Text] [Related]
27. QSAR study of isatin analogues as in vitro anti-cancer agents.
Sabet R; Mohammadpour M; Sadeghi A; Fassihi A
Eur J Med Chem; 2010 Mar; 45(3):1113-8. PubMed ID: 20056518
[TBL] [Abstract][Full Text] [Related]
28. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
Nandi S; Vracko M; Bagchi MC
Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
[TBL] [Abstract][Full Text] [Related]
29. Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth.
Landen JW; Hau V; Wang M; Davis T; Ciliax B; Wainer BH; Van Meir EG; Glass JD; Joshi HC; Archer DR
Clin Cancer Res; 2004 Aug; 10(15):5187-201. PubMed ID: 15297423
[TBL] [Abstract][Full Text] [Related]
30. Structural Basis of Noscapine Activation for Tubulin Binding.
Oliva MA; Prota AE; Rodríguez-Salarichs J; Bennani YL; Jiménez-Barbero J; Bargsten K; Canales Á; Steinmetz MO; Díaz JF
J Med Chem; 2020 Aug; 63(15):8495-8501. PubMed ID: 32657585
[TBL] [Abstract][Full Text] [Related]
31. CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity.
Liao SY; Qian L; Miao TF; Lu HL; Zheng KC
Eur J Med Chem; 2009 Jul; 44(7):2822-7. PubMed ID: 19167135
[TBL] [Abstract][Full Text] [Related]
32. Taking aim at a dynamic target: Noscapinoids as microtubule-targeted cancer therapeutics.
Lopus M; Naik PK
Pharmacol Rep; 2015 Feb; 67(1):56-62. PubMed ID: 25560576
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
34. Rational design, chemical synthesis and cellular evaluation of novel 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents.
Patel AK; Meher RK; Reddy PK; Pedapati RK; Pragyandipta P; Kantevari S; Naik MR; Naik PK
J Mol Graph Model; 2021 Jul; 106():107933. PubMed ID: 33991960
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and 3D-QSAR of beta-carboline derivatives as potent antitumor agents.
Cao R; Guan X; Shi B; Chen Z; Ren Z; Peng W; Song H
Eur J Med Chem; 2010 Jun; 45(6):2503-15. PubMed ID: 20304536
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of noscapine analogues as microtubule-interfering agents.
Dai HL; Zheng JB; Lin M; Zheng J; Zhou FS; Dong XC; Guo L; Liu JW; Wen R
Yao Xue Xue Bao; 2012 Oct; 47(10):1347-57. PubMed ID: 23289148
[TBL] [Abstract][Full Text] [Related]
37. Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.
Mishra RC; Karna P; Gundala SR; Pannu V; Stanton RA; Gupta KK; Robinson MH; Lopus M; Wilson L; Henary M; Aneja R
Biochem Pharmacol; 2011 Jul; 82(2):110-21. PubMed ID: 21501599
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives.
Chen J; Dong X; Liu T; Lou J; Jiang C; Huang W; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 May; 17(9):3324-31. PubMed ID: 19359185
[TBL] [Abstract][Full Text] [Related]
39. Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.
Aneja R; Vangapandu SN; Lopus M; Chandra R; Panda D; Joshi HC
Mol Pharmacol; 2006 Jun; 69(6):1801-9. PubMed ID: 16517755
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of novel biaryl type α-noscapine congeners.
Manchukonda NK; Naik PK; Sridhar B; Kantevari S
Bioorg Med Chem Lett; 2014 Dec; 24(24):5752-5757. PubMed ID: 25453814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]